Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Bristol-Myers Squibb Co., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	15,726)	12,599)	10,875)	10,346)	7,890)	6,293)	9,330)	11,464)	7,514)	8,372)	8,995)	9,123)	7,734)	10,750)	12,369)	13,979)	13,540)	11,024)	10,982)	14,546)	19,435)	19,934)	15,817)
Marketable debt securities	776)	1,004)	907)	513)	204)	360)	340)	816)	171)	358)	274)	130)	1,293)	2,478)	2,599)	2,987)	2,123)	1,946)	1,948)	1,285)	1,720)	1,724)	2,505)
Receivables	11,422)	11,415)	10,801)	10,747)	11,026)	11,423)	10,447)	10,921)	10,304)	10,112)	10,054)	9,886)	9,613)	9,054)	8,511)	9,369)	9,245)	9,017)	8,660)	8,501)	8,062)	7,855)	8,290)
Inventories	2,758)	2,737)	2,666)	2,557)	3,332)	3,077)	2,985)	2,662)	2,436)	2,364)	2,605)	2,339)	2,074)	2,142)	2,104)	2,095)	2,163)	2,137)	1,953)	2,074)	1,949)	2,384)	2,836)
Other current assets	4,948)	5,467)	5,534)	5,617)	5,623)	5,737)	5,567)	5,907)	7,207)	6,868)	5,158)	5,795)	6,082)	5,762)	4,538)	4,832)	4,372)	5,037)	3,568)	3,786)	3,111)	2,446)	2,405)
Current assets	35,630)	33,222)	30,783)	29,780)	28,075)	26,890)	28,669)	31,770)	27,632)	28,074)	27,086)	27,273)	26,796)	30,186)	30,121)	33,262)	31,443)	29,161)	27,111)	30,192)	34,277)	34,343)	31,853)
Property, plant and equipment	7,349)	7,373)	7,213)	7,136)	6,903)	6,845)	6,750)	6,646)	6,481)	6,355)	6,279)	6,255)	6,035)	5,970)	6,047)	6,049)	5,868)	5,795)	5,763)	5,886)	5,740)	5,777)	6,112)
Goodwill	21,745)	21,776)	21,737)	21,719)	21,751)	21,732)	21,738)	21,169)	21,147)	21,163)	21,162)	21,149)	21,112)	20,446)	20,500)	20,502)	20,519)	20,529)	20,524)	20,547)	20,517)	20,578)	22,452)
Other intangible assets	20,465)	21,378)	22,486)	23,307)	26,964)	29,428)	32,760)	27,072)	28,950)	31,303)	33,569)	35,859)	38,179)	37,690)	40,103)	42,527)	44,930)	48,065)	50,819)	53,243)	56,698)	59,171)	61,666)
Deferred income taxes	4,961)	4,647)	3,997)	4,236)	3,609)	3,323)	2,723)	2,768)	1,514)	1,572)	1,317)	1,344)	1,329)	1,337)	1,418)	1,439)	684)	650)	793)	1,161)	913)	1,088)	605)
Marketable debt securities	406)	346)	344)	320)	324)	357)	367)	364)	325)	—)	—)	—)	—)	—)	—)	—)	46)	143)	288)	433)	495)	523)	651)
Other non-current assets	6,333)	5,934)	5,867)	6,105)	6,044)	6,071)	6,024)	5,370)	5,214)	5,022)	4,868)	4,940)	4,745)	4,728)	4,845)	5,535)	7,403)	6,454)	7,137)	7,019)	6,896)	6,596)	5,946)
Non-current assets	61,259)	61,454)	61,644)	62,823)	65,595)	67,756)	70,362)	63,389)	63,631)	65,415)	67,195)	69,547)	71,400)	70,171)	72,913)	76,052)	79,450)	81,636)	85,324)	88,289)	91,259)	93,733)	97,432)
Total assets	96,889)	94,676)	92,427)	92,603)	93,670)	94,646)	99,031)	95,159)	91,263)	93,489)	94,281)	96,820)	98,196)	100,357)	103,034)	109,314)	110,893)	110,797)	112,435)	118,481)	125,536)	128,076)	129,285)

Cash and cash equivalents: The cash position fluctuated significantly, starting at a high point in early 2020, declining toward the end of 2021, and then showing recovery with notable increases in early 2024 and thereafter. This indicates periods of liquidity tightening followed by improved cash generation or financing activities.
Marketable debt securities (current portion): Marketable debt securities showed a general decline through 2022, reaching minimal values by the end of that year, before a modest rebound during 2023 and fluctuations in 2024 and 2025. This suggests a reduction in short-term investments followed by some reinstatement of these instruments.
Receivables: Receivables have experienced an overall gradual increase from 2020 through 2025, with some volatility. The rising trend in receivables points to increasing sales or extended credit terms over time.
Inventories: Inventories declined during the initial periods of 2020 but trended upwards from 2022 onward, peaking around late 2024 before stabilizing. The increase could indicate stockpiling in anticipation of higher demand or slower inventory turnover.
Other current assets: Other current assets increased considerably from 2020 to 2021, reaching a peak in mid-2023 before exhibiting a decline heading into 2025. This volatility might reflect changes in prepaid expenses, advances, or other receivables components.
Current assets: Current assets overall decreased from early 2020 through 2022 but started to rise again from 2023, culminating in a higher level by early 2025. This pattern mirrors the movements in cash, receivables, and other components.
Property, plant and equipment: The value of property, plant, and equipment exhibited a moderate and steady upward trend across the entire period, indicating ongoing investments in fixed assets and capacity expansion.
Goodwill: Goodwill remained relatively stable with minor fluctuations, maintaining a value slightly above 20 billion USD throughout the timeline, suggesting limited new acquisitions or impairment events.
Other intangible assets: Other intangible assets showed a marked downward trend from about 61 billion USD in early 2020 to below 21 billion USD by late 2025. This steady decline likely reflects ongoing amortization and possibly divestitures or impairment of intangible assets.
Deferred income taxes: Deferred income tax amounts generally increased over the period, particularly from 2023 onward, more than doubling by late 2024 and 2025. This suggests growing timing differences between book and tax income or changes in tax regulations affecting deferred tax liabilities or assets.
Marketable debt securities (non-current portion): Non-current marketable debt securities decreased substantially from 2020 to about 2021 and were not reported for a period before reappearing at moderate levels from 2023 onwards. This irregular pattern indicates shifts in long-term investment strategies.
Other non-current assets: Other non-current assets fluctuated modestly, with no clear directional trend, suggesting relatively stable levels of long-term miscellaneous assets.
Non-current assets: Non-current assets declined steadily from over 97 billion USD in early 2020 to just above 61 billion USD in late 2025. This overall decrease is largely driven by reductions in intangible assets and modest changes in other categories.
Total assets: Total assets showed a clear declining trend from approximately 129 billion USD in early 2020 to below 95 billion USD by the end of 2025, indicating overall contraction in asset base, mainly attributable to decreases in non-current assets and fluctuations in current assets.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Bristol-Myers Squibb Co. (NYSE:BMY)

Balance Sheet: Assets Quarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data